White House Drug Strategy Declares Hemp-Derived THC Products Schedule I The 2026 National Drug Control Strategy treats delta-8, delta-10, THC-O, and similar hemp derivatives as…
cbdMD Closes Bluebird Botanicals Acquisition as Industry Consolidation Accelerates The deal adds patented extraction technology and regulatory documentation to cbdMD’s portfolio as companies race to…
Five New Studies Show CBD Targets Breast Cancer Cells Through Multiple Pathways Lab and animal research published in 2026 points to CBD’s potential against several…
Texas Court Blocks Smokable Hemp Ban as Industry Challenges 4,000% Fee Hikes A temporary injunction puts hemp flower back on Texas shelves, but the real…
House Passes 2026 Farm Bill With Hemp Product Ban Intact as Senate Battle Looms The clock is ticking for a $28 billion industry as the…
Largest-Ever Dog CBD Study Finds Unexpected Aggression Pattern Across 47,000 Animals Data from the Dog Aging Project reveals a complex relationship between long-term CBD supplementation…
cbdMD Opens Clinical Healthcare Channel as Medicare Activates CBD Access for First Time The publicly traded CBD company positions itself at the front of a…